Advertisement

10 Responses

  1. Kevin McMahon
    Kevin McMahon November 28, 2012 at 7:36 am | | Reply

    Those who ignore history are doomed to repeat it. What percentage of your attendees are familiar with the research trial published recently in Diabetes Care entitled, “Integrating an Automated Diabetes Management System into the family management of Children with Type 1 Diabetes”, Diabetes Care-3/2012? While I know many of the people in the room, I suspect that few if any have read the abstract let alone the full manuscript. If results from a randomized controlled clinical trial that took 6 years to accomplish which included mobile devices, a cloud based expert system and automated diabetes care coordination aren’t sufficiently interesting to this audience then how in the world do you expect to get the attention of payers? Lack of awareness may also indicate a gap in information sharing and a willingness to collaborate which extends the time before adoption of innovations because everyone would like to pretend that the problem hasn’t been solved yet and key advancements are repeated rather than built upon. A similar experience occurred at the 2003 Diabetes Technology Meeting during a session on “Why lack of data standardization is a barrier to innovation”. During the sessions Q&A, my CTO, Eric Link, showed the first truly integrated and automated mobile blood glucose data management device (aka GlucoMON) if only to dispel the myth. Needless to say the audience was unaware and not interested in the proof that universal data standardization is not a prerequisite and need not be a barrier. The abstract can be viewed online at PubMed.gov: http://j.mp/t1pedsStudyPubMed Disclosure: I am the CEO of Diabetech and am much happier these days since most of my time is spent on projects that do not involve overcoming barriers to diabetes innovation and modernization.

  2. Bennet
    Bennet November 28, 2012 at 11:00 am | | Reply

    Pontificating. Love it.

  3. Gary
    Gary November 30, 2012 at 5:02 am | | Reply

    Another perspective from those of us outside the product development and approval world – I can’t think of any medical advance for this disease during the time I have had it (1995). Ok, Lantus was a big help but even that was available in other countries long before I could get it. My meter is a faster version of the one I had then and still is permitted the same error percentage. Insurance companies decide what meter I can have, will not fund a CGM unless I am really way out of control and only a few really track and follow up with newly diagnosed patients. Islet transplants and other steps would appear to an ordinary person like me to something generations and billions of dollars away.

  4. Susan Whittier
    Susan Whittier November 30, 2012 at 9:49 am | | Reply

    “Data is useless unless you can analyze it; as a clinician with diabetes data it’s all about how it is presented, how it’s displayed. ………. But when they bring it in, the data is useless and this is the reason clinics ask their patients to use logbooks. Because a lot of the software that is out there just doesn’t present the data in a friendly way.” – one of the clinicians present……”

    I have heard this so many times – it’s not only frustrating, it’s disgusting. If a physician who is being paid in the top 10% of salaried earners can’t interpret a graphic spread sheet, then they need to hire someone to reformat the electronic data so both parties can comprehend / discuss the report. Discussion is a necessary part of education for the PWD. This means of course funds spent on hiring assitants is what the patient is paying the MD to do when the MD is not able to perform that skill without help. Sorry – one less summer cottage I guess.

    Medicine never has been a linear profession – and again we see the physician walking in a straight line with blinders on.

  5. Kevin McMahon
    Kevin McMahon December 3, 2012 at 3:18 pm | | Reply

    Sharing bit.ly stats with you from the link to the study abstract hosted on PubMed.gov: 5 clicks total (3 from USA and 2 from Canada).

  6. Rethinking diabetes management and care | Scope Blog

    [...] a recap of the summit on her blog, Tenderich explained that this year’s event was less about product [...]

  7. Rethinking diabetes management and care | Scope Blog | Diabetes Information

    [...] a recap of the summit on her blog, Tenderich explained that this year’s event was less about product [...]

  8. Rethinking diabetes management and care | Diabetes Information

    [...] a recap of the summit on her blog, Tenderich explained that this year’s event was less about product [...]

  9. Rethinking diabetes management and care « Insulin Nation - This is the tagline

    [...] a recap of the summit on her blog, Tenderich explained that this year’s event was less about product [...]

Leave a Reply